Drug Patent Watch

FEBRUARY 4, 2024

NATESTO (testosterone) Acerus Patent: 8,784,869 Expiration: Feb 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit… The post Drug Patent Expirations for the Week of February 4, 2024 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Pharmaceuticals 59

FDA Law Blog: Biosimilars

FEBRUARY 4, 2024

By Steven J. Gonzalez & Gail H. Javitt & Allyson B. Mullen — On January 18, 2024, the director of FDA’s Center for Devices and Radiological Health and the chief medical officer and acting director of CMS’ Center for Clinical Standards and Quality issued a joint press release supporting FDA’s recent proposed rule regulating Laboratory Developed Tests (LDTs).

FDA 59

FDA Laboratories Regulations Compliance 59

Drug Patent Watch

FEBRUARY 4, 2024

Annual Drug Patent Expirations for INJECTAFER Injectafer is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are ten patents… The post New patent expiration for Am Regent drug INJECTAFER appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

KIF1A

FEBRUARY 4, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research Large-Scale Whole-Genome Analysis of HTLV-1–Associated Myelopathy Identified Hereditary Spastic Paraplegias Many disorders look similar to each other when comparing symptoms; there are many cause

RNA 52

RNA DNA Disease Trials 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drug Patent Watch

FEBRUARY 4, 2024

This chart shows the drugs with the most patents in Finland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Finland? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals 104

Pharmaceuticals Drugs 104